An interventional study of Exercise program in Interstitial Lung Disease, sponsored by Izmir Katip Celebi University. Completed. Per ClinicalTrials.gov, last updated 2017-10-05.
Sponsored by Izmir Katip Celebi University · Not applicable, Interventional, and Treatment
We aimed to compare the functional results of the 8th week with the results of the 12th week of the exercise programs applied to the patients with ILD.
Exercise programs (EP) have been shown to be the effective approach for functional outcomes in interstitial lung diseases (ILD). In many studies, the duration of exercise programs varies between 8-12 weeks. However, the optimal duration of exercise program is still unknown.
We aimed to compare the results of the 8th week with the results of the 12th week of the PR programs applied to the patients with ILD.
A total of 14 patients with ILD referred to our PR unit [11 idiopathic pulmonary fibrosis, 2 sarcoidosis (stage 3 and 4) and 1 nonspecific interstitial pneumonia] were included in the study. Pulmonary function test, arterial blood gas analysis, 6- minute walk test, mMRC dyspnea scale, quality of life questionnaires and hospital anxiety depression scale were performed before, at the 8th and 12th weeks after the exercise program applied to the patients twice a week.
680 studies on the registry are indexed under Lung Diseases, Interstitial; 246 are open to participants now.
This study's enrollment of 14 is below the median of 60 across 384 interventional studies indexed under Lung Diseases, Interstitial.
Browse Lung Diseases, Interstitial studies →Izmir Katip Celebi University is the lead sponsor of 198 studies on the registry; 39 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Treatment group
Other: Exercise program
Exercise program including breathing control, pursed-lip breathing, diaphragmatic and thoracic breathing, aerobic and strengthening training
Six minute walk test
It was performed in a 30-meter long corridor in accordance with American Thoracic Society criteria
Time frame: 6 minute
mMRC
It was used for dyspnea that patients felt during their daily activities.
Time frame: 5 minutes
Pulmonary Function Test
It was used for assessment of lung functions
Time frame: 20 minutes
SGRQ
A disease-specific quality of life scale
Time frame: 30 minutes
SF-36 Health Survey
A health related quality of life scale
Time frame: 30 minutes
Hospital Anxiety and Depression Inventory
It was used for assessment of anxiety and depression
Time frame: 20 minutes
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
Ran from Jan 2014 to primary completion in Jan 2016, 24 months.
Of 114 non-industry interventional studies with no phase under Lung Diseases, Interstitial, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 46. This study's 24 months is below that.
Counting every sponsor, half of 118 studies reached it within 27 months; a quarter within 14 and three quarters within 44.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Oct 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Izmir Katip Celebi University →